Maetrics has appointed Elizma Parry as director of global clinical practice.
A highly-qualified industry professional, she is a proven leader with a strong track record of clinical safety, regulatory, and quality management experience.
She is leading the company’s clinical practice which is dedicated to delivering effective clinical and performance evidence for international medical device and IVD regulatory compliance.
Parry brings over 25 years of experience to the Maetrics team.
Having recently been in a shared acting role as the head of a Europe-based Notified Body before joining Maetrics, she was also managing a multi-national clinical team within the Notified Body that was responsible for the clinical safety, performance, and clinical benefit conformity assessments of medical device manufacturers’ clinical evidence, as well as the clinical lead for liaising with the MHRA.
She will provide Maetrics’ clients with expert counsel in the clinical practice environment.
Parry has also worked across quality, regulatory and biotechnology environments throughout her career, developing and presenting training courses across the UK and USA, including joint development of a bespoke Cranfield University course for Notified Body clinical assessors.
Steve Cottrell, president at Maetrics, said: “We are thrilled that Elizma is joining the Maetrics management team.
“Her talent and experience, combined with Maetrics’ specialist offering in international medical device and IVD regulatory compliance, means life science companies can trust Maetrics to deliver the right clinical solutions, guidance and support to maintain their products in the European and global markets.”
